Company Information

Company Profile

PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. The PolarityTE platform technology begins with a small piece of the patient's own, or autologous, healthy tissue, rather than artificially manipulated individual cells. From this small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to enhance and stimulate the patient's own cells to regenerate the target tissues. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures with the patient's own tissue and uses the patient's own body to support the regenerative process to create the same tissue from which it was derived. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.

Latest Investor Presentation

Investor Presentation

Contact Information

Investor Relations
Rich Haerle
VP of Investor Relations & Corporate Strategy
T: 385-831-5284
ir@polarityte.com

Transfer Agent
Equity Stock transfer
237 W 37th St, Suite 602
New York, NY 10018
T: 212-575-5757
F: 347-584-3644

Legal Counsel
Parsons Behle & Latimer
201 South Main Street, Suite 1800
Salt Lake City, UT 84111
T: 801-532-1234

Company Contact
PolarityTE, Inc.
123 North Wright Brothers Drive,
Salt Lake City, UT 84116

Auditor
EisnerAmper LLP